Juzentaihoto, a Kampo medicine, enhances IL-12 production by modulating Toll-like receptor 4 signaling pathways in murine peritoneal exudate macrophages.

Source:http://linkedlifedata.com/resource/pubmed/id/15778123

Download in:

View as

General Info

PMID
15778123